Gynecology & Obstetrics Updates

Kanalga Telegram’da o‘tish

All the atest articles, research and news from worlds leading Gynecology and Obstetrics Journals. Discussion group https://t.me/Professional_Medical_Discussion

Ko'proq ko'rsatish

AQSH3 087 Tibbiyot2 384...

📈 Telegram kanali Gynecology & Obstetrics Updates analitikasi

Gynecology & Obstetrics Updates (@gynobsupdates) Ingliz til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 11 358 obunachidan iborat bo'lib, Tibbiyot toifasida 2 384-o'rinni va AQSH mintaqasida 3 087-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 11 358 obunachiga ega bo‘ldi.

05 Oktabr, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 219 ga, so‘nggi 24 soatda esa -1 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

Tasdiqlash holati: Tasdiqlanmagan
Jalb etish (ER): Auditoriya o‘rtacha 9.54% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 2.54% ini tashkil etuvchi reaksiyalarni to‘playdi.
Post qamrovi: Har bir post o‘rtacha 1 083 marta ko‘riladi; birinchi sutkada odatda 289 ta ko‘rish yig‘iladi.
Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 1 ta reaksiya keladi.
Tematik yo‘nalishlar: Kontent pregnancy, editor, cohort, birth, cancer kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
“All the atest articles, research and news from worlds leading Gynecology and Obstetrics Journals. Discussion group https://t.me/Professional_Medical_Discussion”

Yuqori yangilanish chastotasi (oxirgi ma’lumot 06 Oktabr, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

11 358

Obunachilar

-124 soatlar

+437 kun

+21930 kun

1 083

Post ko'rishlar

~ 28924 soatlar

~ 39748 soatlar

9.54%

Muloqot nisbati

~ 2

Kuniga postlar

Ads index

beta

Postlar arxiv

11 357

Infectious morbidity and microbiological findings in early and late preterm prelabor rupture of membranes managed expectantly https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71394?af=R

11 357

From guidelines to delivery rooms: Accelerating global action to end preventable deaths from postpartum hemorrhage https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71397?af=R

11 357

From guidelines to practice: A call for FIGO member societies to lead the way to end postpartum hemorrhage https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71396?af=R

11 357

From World Health Organization's call to Somalia's action: One antenatal platform for three eliminations https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71390?af=R

11 357

Reproductive violence in Morocco: Mixed‐methods study to measure associations and experiences of reproductive violence among Moroccan and non‐Moroccan women https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71367?af=R

11 357

Reinterpreting cervical cerclage classification: Diagnostic detection and operative context https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71385?af=R

11 357

Methodological considerations of NBN-associated ovarian cancer risk (Letter-to-the-Editor) https://www.ajog.org/article/S0002-9378(26)00535-1/fulltext?rss=yes

11 357

Interpreting the specialist-access gradient in gynecologic cancer stage at diagnosis (Letter-to-the-Editor) https://www.ajog.org/article/S0002-9378(26)00537-5/fulltext?rss=yes

11 357

NBN is associated with an increased risk of ovarian cancer (Reply to Letter-to-the-Editor) https://www.ajog.org/article/S0002-9378(26)00536-3/fulltext?rss=yes

11 357

Geographic Accessibility and Calendar Period in Gynecologic Cancer Stage at Diagnosis (Reply to Letter-to-the-Editor) https://www.ajog.org/article/S0002-9378(26)00538-7/fulltext?rss=yes

11 357

Survival Outcomes of Ovarian-Sparing Surgery for Early-Stage Adult Granulosa Cell Tumor https://www.ajog.org/article/S0002-9378(26)00539-9/fulltext?rss=yes

11 357

When doctors falter: Resilience in modern obstetrics and gynecology, a narrative review https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71327?af=R

11 357

Acupressure for postoperative pain after cesarean delivery: A meta‐analysis https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.70994?af=R

11 357

Effect of preoperative intravenous iron administration on transfusion outcomes in benign gynecologic surgery https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71013?af=R

11 357

Successful in vitro fertilization in a patient with bicornuate uterus in Uzbekistan: A first reported case https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71058?af=R

11 357

Systemic inflammatory indices as predictors of adverse outcomes in pregnancies with vascular events: A retrospective cohort study https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71056?af=R

11 357

From prevalence to precision: Integrating phenotype, symptoms, reproductive goals, and treatment in leiomyoma care https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71262?af=R

11 357

Efficacy‐oriented approach for medium‐sized follicles: A perspective on stimulation, expectation, and triggering strategy in IVF cycles https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71009?af=R

11 357

Development and temporal validation of a nationwide prediction model for cesarean delivery after induction or augmentation of labor in Japan https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71024?af=R

11 357

Comparative effectiveness of curettage, uterine artery embolization, and gonadotropin‐releasing hormone (GnRH) agonist therapy in the management of acquired uterine enhanced myometrial vascularity/arteriovenous malformation (EMV/AVM) and retained products of conception (RPOC): A retrospective cohort study https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71010?af=R